A detailed history of Palisades Investment Partners, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Palisades Investment Partners, LLC holds 160,108 shares of TMDX stock, worth $12.1 Million. This represents 4.21% of its overall portfolio holdings.

Number of Shares
160,108
Previous 148,785 7.61%
Holding current value
$12.1 Million
Previous $23.4 Billion 57.26%
% of portfolio
4.21%
Previous 10.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$59.28 - $144.9 $671,227 - $1.64 Million
11,323 Added 7.61%
160,108 $9.98 Billion
Q3 2024

Feb 18, 2025

BUY
$135.68 - $176.11 $1.23 Million - $1.59 Million
9,048 Added 6.48%
148,785 $23.4 Billion
Q2 2024

Feb 18, 2025

BUY
$72.62 - $150.62 $10.1 Million - $21 Million
139,737 New
139,737 $21 Billion

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.4B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Palisades Investment Partners, LLC Portfolio

Follow Palisades Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisades Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisades Investment Partners, LLC with notifications on news.